AerovectRx
closedDevelops pulmonary drug delivery technology.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | N/A | Seed | |
| Total Funding | 000k | ||
Related Content
AerovectRx Corporation was established to capitalize on the growing market for aerosol-based therapeutics, focusing on pulmonary drug delivery. The company was founded by Matthew H.J. Kim, J.D., an entrepreneur with a background in life sciences ventures who also founded Vigilant Biosciences in 2011. The foundational technology for AerovectRx was licensed from the U.S. Centers for Disease Control and Prevention, providing a strong basis for its development efforts.
The company's core business revolves around a proprietary unit-dose aerosol drug delivery platform. A key milestone was achieved in April 2006, when AerovectRx received FDA 510(k) clearance to market its vibrating mesh nebulizer system equipped with a disposable medication cartridge. This product, the AeroCell disposable drug cartridge, was central to the company's business model. The model was designed to generate a recurring revenue stream from the sale of these single-use cartridges, moving beyond the one-time sale of a hardware device.
AerovectRx's platform was engineered to offer a painless and efficient alternative to injections for a variety of high-value medications. The system functions by delivering controlled doses of therapeutics through the respiratory system. The company targeted a wide spectrum of medical applications for its technology, including treatments for chronic conditions such as asthma, cystic fibrosis, pulmonary hypertension, and Chronic Obstructive Pulmonary Disease (COPD). Furthermore, the platform was positioned for applications in diabetes care, pain management, and the delivery of vaccines and anti-viral drugs.
Keywords: pulmonary drug delivery, aerosol therapeutics, nebulizer technology, respiratory medicine, drug delivery systems, vibrating mesh nebulizer, unit-dose delivery, disposable cartridge, inhalation therapy, CDC license, FDA 510(k) clearance, life sciences, medical devices, AeroCell, asthma treatment, COPD treatment, cystic fibrosis therapy, vaccine delivery, anti-viral delivery, pain management delivery